- Home
- TAOP vs RDHL Comparison
TAOP vs RDHL Comparison
Compare TAOP & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAOP
- RDHL
- Stock Information
- Founded
- TAOP 1993
- RDHL 2009
- Country
- TAOP China
- RDHL Israel
- Employees
- TAOP N/A
- RDHL 35
- Industry
- TAOP Computer Software: Prepackaged Software
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- TAOP Technology
- RDHL Health Care
- Exchange
- TAOP Nasdaq
- RDHL Nasdaq
- Market Cap
- TAOP 4.8M
- RDHL 3.9M
- IPO Year
- TAOP N/A
- RDHL N/A
- Fundamental
- Price
- TAOP $4.13
- RDHL $1.63
- Analyst Decision
- TAOP
- RDHL
- Analyst Count
- TAOP 0
- RDHL 0
- Target Price
- TAOP N/A
- RDHL N/A
- AVG Volume (30 Days)
- TAOP 27.7K
- RDHL 1.4M
- Earning Date
- TAOP 09-04-2025
- RDHL 08-28-2025
- Dividend Yield
- TAOP N/A
- RDHL N/A
- EPS Growth
- TAOP N/A
- RDHL N/A
- EPS
- TAOP N/A
- RDHL N/A
- Revenue
- TAOP $36,672,512.00
- RDHL $8,042,999.00
- Revenue This Year
- TAOP N/A
- RDHL $381.91
- Revenue Next Year
- TAOP N/A
- RDHL N/A
- P/E Ratio
- TAOP N/A
- RDHL N/A
- Revenue Growth
- TAOP N/A
- RDHL 23.17
- 52 Week Low
- TAOP $3.56
- RDHL $1.62
- 52 Week High
- TAOP $29.40
- RDHL $20.28
- Technical
- Relative Strength Index (RSI)
- TAOP 37.83
- RDHL 40.75
- Support Level
- TAOP $4.09
- RDHL $1.86
- Resistance Level
- TAOP $4.51
- RDHL $3.31
- Average True Range (ATR)
- TAOP 0.41
- RDHL 0.29
- MACD
- TAOP 0.03
- RDHL -0.05
- Stochastic Oscillator
- TAOP 33.02
- RDHL 0.59
About TAOP Taoping Inc.
Taoping Inc is a provider of cloud-app technologies for smart city IoT platforms, digital advertising delivery, and other internet-based information distribution systems in China. Its operating segment includes Cloud-based Technology (CBT), Blockchain Technology (BT), and Traditional Information Technology (TIT). It generates maximum revenue from the CBT segment. CBT segment includes cloud-based products and services offered to customers in the private sector including new media, healthcare, education, and residential community management.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.